These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 8946428
21. Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls. Siegel BV, Nuechterlein KH, Abel L, Wu JC, Buchsbaum MS. Schizophr Res; 1995 Sep; 17(1):85-94. PubMed ID: 8541254 [Abstract] [Full Text] [Related]
24. Regional lumped constant differences and asymmetry in fluorine-18-FDG uptake in temporal lobe epilepsy. Reutens DC, Gjedde AH, Meyer E. J Nucl Med; 1998 Jan; 39(1):176-80. PubMed ID: 9443758 [Abstract] [Full Text] [Related]
25. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. Potkin SG, Alva G, Fleming K, Anand R, Keator D, Carreon D, Doo M, Jin Y, Wu JC, Fallon JH. Am J Psychiatry; 2002 Feb; 159(2):227-37. PubMed ID: 11823264 [Abstract] [Full Text] [Related]
26. High-resolution PET studies in Alzheimer's disease. Kumar A, Schapiro MB, Grady C, Haxby JV, Wagner E, Salerno JA, Friedland RP, Rapoport SI. Neuropsychopharmacology; 1991 Jan; 4(1):35-46. PubMed ID: 2003867 [Abstract] [Full Text] [Related]
28. Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance. Carter CS, Mintun M, Nichols T, Cohen JD. Am J Psychiatry; 1997 Dec; 154(12):1670-5. PubMed ID: 9396944 [Abstract] [Full Text] [Related]
30. Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease. Kuwert T, Noth J, Scholz D, Schwarz M, Lange HW, Töpper R, Herzog H, Aulich A, Feinendegen LE. Mov Disord; 1993 Dec; 8(1):98-106. PubMed ID: 8419813 [Abstract] [Full Text] [Related]
32. Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features. Gur RE, Mozley PD, Resnick SM, Mozley LH, Shtasel DL, Gallacher F, Arnold SE, Karp JS, Alavi A, Reivich M. Arch Gen Psychiatry; 1995 Aug; 52(8):657-67. PubMed ID: 7632119 [Abstract] [Full Text] [Related]
33. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method. Schmidt K, Lucignani G, Moresco RM, Rizzo G, Gilardi MC, Messa C, Colombo F, Fazio F, Sokoloff L. J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447 [Abstract] [Full Text] [Related]
34. "Hyperfrontality" as seen on FDG PET in unmedicated schizophrenia patients with positive symptoms. Shinto AS, Kamaleshwaran KK, Srinivasan D, Paranthaman S, Selvaraj K, Pranesh MB, Lakshminarayanan GN, Prakash B. Clin Nucl Med; 2014 Aug; 39(8):694-7. PubMed ID: 24978342 [Abstract] [Full Text] [Related]